Business
Rybakina withdraws from Tokyo quarter-finals with neck injury
By Marcus Chen
Advertisement · Why this ad?
Indian regulators have escalated action against India's largest drugmaker, Sun Pharma, barring ophthalmic drug production at its Assam factory until it submits a satisfactory compliance report.